Decreasing malaria prevalence and its potential consequences for immunity in pregnant women

Journal of Infectious Diseases

Volumn 210, Issue 9, 2014, Pages 1444-1455

  Teo, Andrew ^a   Hasang, Wina ^a   Randall, Louise M ^a   Feng, Gaoqian ^c   Bell, Lauren ^a   Unger, Holger ^a   Langer, Christine ^c   Beeson, James G ^c   Siba, Peter M ^d   Mueller, Ivo ^b,e   Molyneux, Malcolm E ^f,g   Brown, Graham V ^a   Rogerson, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c BURNET INSTITUTE   (Australia)

^d PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f UNIVERSITY OF MALAWI   (Malawi)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Acquisition; Antibody; Longer lasting; Malawi; Papua New Guinea; Plasmodium falciparum; Pregnancy

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; IMMUNOGLOBULIN G; INSECTICIDE; MEROZOITE ANTIGEN; PARASITE ANTIGEN; PYRIMETHAMINE PLUS SULFADOXINE; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; VAR2CSA DBL5 EPSILON ANTIGEN; PROTOZOON ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BED NET; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNITY; INFECTED ERYTHROCYTE; MALARIA; MALAWIAN; NONHUMAN; OPSONIZATION; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCHIZONT; SEROLOGY; SINGLE DRUG DOSE; ADULT; BLOOD; IMMUNOLOGY; INNATE IMMUNITY; MALARIA, FALCIPARUM; MALAWI; PREGNANCY; PREGNANCY COMPLICATION; YOUNG ADULT;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALAWI; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; YOUNG ADULT;

EID: 84922021675     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu264     Document Type: Article

References (46)

1. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature 1998; 395:851-2.
2. Rijken MJ, McGready R, Boel ME, et al. Malaria in pregnancy in the Asia-Pacific region. Lancet Infect Dis 2012; 12:75-88.
3. Beeson JG, Reeder JC, Rogerson SJ, Brown GV. Parasite adhesion and immune evasion in placental malaria. Trends Parasitol 2001; 17:331-7.
4. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:1502-4.
5. Ricke CH, Staalsoe T, Koram K, et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 2000; 165:3309-16.
6. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis 1999; 180:464-72.
7. Rogerson SJ, Pollina E, Getachew A, Tadesse E, Lema VM, Molyneux ME. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 2003; 68:115-9.
8. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61:1005-16.
9. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
10. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363:283-9.
11. Aitken EH, Mbewe B, Luntamo M, et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. PLoS One 2012; 7:e29874.
12. Staalsoe T, Shulman CE, Dorman EK, Kawuondo K, Marsh K, Hviid L. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria. Infect Immun 2004; 72:5027-30.
13. Staalsoe T, Megnekou R, Fievét N, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 2001; 184:618-26.
14. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860-7.
15. Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets. PLoS One 2010; 5:e12012.
16. Gnidehou S, Jessen L, Gangnard S, et al. Insight into antigenic diversity of VAR2CSA-DBL5epsilon domain from multiple Plasmodium falciparum placental isolates. PLoS One 2010; 5:e13105.
17. Beeson JG, Mann EJ, Elliott SR, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis 2004; 189:540-51.
18. Chandrasiri UP, Randall LM, Saad AA, Bashir AM, Rogerson SJ, Adam I. Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy. J Infect Dis 2014; 209:1408-17.
19. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26:171-6.
20. Ataíde R, Hasang W, Wilson DW, et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS One 2010; 5:e10807.
21. Stanisic DI, Richards JS, McCallum FJ, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009; 77:1165-74.
22. Persson KE, McCallum FJ, Reiling L, et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 2008; 118:342-51.
23. Osier FH, Fegan G, Polley SD, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008; 76:2240-8.
24. Reiling L, Richards JS, Fowkes FJ, et al. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol 2010; 185:6157-67.
25. Fowkes FJ, McGready R, Cross NJ, et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis 2012; 206:1612-21.
26. Avril M, Cartwright MM, Hathaway MJ, et al. Immunization with VAR2CSA-DBL5 Recombinant Protein Elicits Broadly Cross-Reactive Antibodies to Placental Plasmodium falciparum-Infected Erythrocytes. Infect Immun 2010; 78:2248-56.
27. Boyle MJ, Wilson DW, Richards JS, et al. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc Natl Acad Sci U S A 2010; 107:14378-83.
28. Aitken EH, Mbewe B, Luntamo M, et al. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J Infect Dis 2010; 201:1316-25.
29. Salanti A, Dahlback M, Turner L, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004; 200: 1197-203.
30. Moncunill G, Mayor A, Jimenez A, et al. High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One 2013; 8:e73624.
31. Vestergaard LS, Lusingu JP, Nielsen MA, et al. Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania. Infect Immun 2008; 76:2706-14.
32. Kinyanjui S, Conway D, Lanar D, Marsh K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 2007; 6:82.
33. Akpogheneta OJ, Duah NO, Tetteh KK, et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 2008; 76:1748-55.
34. Crompton PD, Kayala MA, Traore B, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010; 107:6958-63.
35. Nebie I, Tiono AB, Diallo DA, et al. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Trop Med Int Health 2008; 13:229-37.
36. Fonjungo PN, Elhassan IM, Cavanagh DR, et al. A longitudinal study of human antibody responses to Plasmodiumfalciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission. Infect Immun 1999; 67:2975-85.
37. Hill DL, Eriksson EM, Li Wai Suen CS, et al. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria. PLoS One 2013; 8:e74627.
38. Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert Rev Vaccines 2011; 10:1405-14.
39. Feng G, Aitken E, Yosaatmadja F, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 2009; 200:299-306.
40. Ataíde R, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ. Antibodies That Induce Phagocytosis of Malaria Infected Erythrocytes: Effect of HIV Infection and Correlation with Clinical Outcomes. PLoS ONE 2011; 6:e22491.
41. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003; 71:6620-3.
42. Fernandez P, Petres S, Mecheri S, Gysin J, Scherf A. Strain-transcendent immune response to recombinant Var2CSA DBL5-epsilon domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. PLoS One 2010; 5:e12558.
43. Magistrado P, Salanti A, Tuikue Ndam NG, et al. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. J Infect Dis 2008; 198:1071-4.
44. Vandemoortele M, Bird K. Improved economic conditions in Malawi: Progress from a low base. http://www.odi.org.uk/publications/5480-malawi-economic-conditions-poverty-development-progress. Accessed 20 April 2014.
45. Malawi Government. 2012 global AIDS response progress report: Malawi country report for 2010 and 2011. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce-MW-Narrative-Report%5B1%5D.pdf. Accessed 20 April 2014.
46. Mayor A, Kumar U, Bardaji A, et al. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. J Infect Dis 2013; 207:1664-74.